NCT07207174

Brief Summary

This randomized controlled trial aims to test both English and Spanish versions of two, benign behavioral interventions for adults with chronic pain -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE), and 2) Brief Cognitive- Behavioral Therapy (B-CBT).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
17mo left

Started Sep 2025

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Sep 2025Sep 2027

First Submitted

Initial submission to the registry

September 17, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

September 26, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2027

Last Updated

November 3, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

September 17, 2025

Last Update Submit

October 31, 2025

Conditions

Keywords

Chronic painSpanish-language interventionMindfulnessCognitive-behavioral TherapyBrief intervention

Outcome Measures

Primary Outcomes (2)

  • Program Feasibility

    Feasibility will be assessed by intervention adherence rates (percentage of treatment sessions completed).

    At the first treatment session [1 hour] and the final treatment session [1 hour]

  • Treatment Acceptability

    Treatment acceptability will be assessed by an adaptation of the Theoretical Framework of Acceptability scale (TFA).

    Upon completion of the final treatment session [1 hour]

Secondary Outcomes (5)

  • Chronic Pain Symptoms

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • Depressive Symptoms

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • Anxiety Symptoms

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • Wellbeing

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • Pain Catastrophizing

    Baseline and 2, 6, and 12-week post-treatment follow-ups

Other Outcomes (11)

  • Credibility/Expectancy

    Immediately upon completion of the first treatment session

  • Mindful Reappraisal of Pain Sensations

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • Trait Decentering

    Baseline and 2, 6, and 12-week post-treatment follow-ups

  • +8 more other outcomes

Study Arms (2)

Brief Behavioral Intervention #1

EXPERIMENTAL

Brief Mindfulness Oriented Recovery Enhancement (B-MORE)

Behavioral: Brief Mindfulness Oriented Recovery Enhancement

Brief Behavioral Intervention #2

EXPERIMENTAL

Brief Cognitive-Behavioral Therapy (B-CBT)

Behavioral: Brief Cognitive-Behavioral Therapy

Interventions

B-MORE is a 2-hour adaptation of the traditional MORE program.

Brief Behavioral Intervention #1

B-CBT is a 2-hour adaptation of a traditional 8-week CBT for Chronic Pain manual.

Brief Behavioral Intervention #2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having a chronic pain condition
  • Average pain of \> 3 in the last week
  • Willingness to engage with study assessments and interventions
  • Understanding English or Spanish instructions fluently
  • Age 18 and above.

You may not qualify if:

  • Unable to consent because of physical or mental incapacity
  • Have previous, formal mindfulness or CBT training (e.g., MBSR)
  • Have pain from a current cancer diagnosis
  • Unstable illness that may interfere with treatment
  • Had surgery within the previous three months
  • Had pain relieving injections, such as cortisone or hyaluronate, within the previous three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Building B

Tallahassee, Florida, 32310, United States

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Adam Hanley, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 17, 2025

First Posted

October 3, 2025

Study Start

September 26, 2025

Primary Completion (Estimated)

September 22, 2027

Study Completion (Estimated)

September 22, 2027

Last Updated

November 3, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

The study protocol, SAP, ICF, and de-identified IPD will be shared with qualified individuals upon request.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
It will be available from study end up to 5 years afterwards.
Access Criteria
Any qualified individual may request the above-mentioned IPD and supporting information from the research team. Research team will provide the above via secure individual correspondence.

Locations